LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

Search

NeoGenomics Inc

Затворен

8.03 -1.23

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

7.98

Максимум

8.09

Ключови измерители

By Trading Economics

Приходи

-11M

-26M

Продажби

-4M

168M

EPS

-0.204

Марж на печалбата

-15.427

Служители

2,200

EBITDA

-10M

-6.3M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+55.28% upside

Дивиденти

By Dow Jones

Следващи печалби

28.07.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-348M

934M

Предишно отваряне

9.26

Предишно затваряне

8.03

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

NeoGenomics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

9.05.2025 г., 11:25 ч. UTC

Печалби

TeraWulf 1Q Loss Widens After Bitcoin Halving Cuts Revenue

8.05.2025 г., 17:06 ч. UTC

Значими двигатели на пазара
Придобивния, сливания и поглъщания

Coinbase Shares Rise After WSJ Reports Its $2.9 Billion Deal for Major Crypto Platform

9.05.2025 г., 15:13 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Coinbase Stock Is Down After Earnings as Bitcoin Keeps Rising -- Barrons.com

9.05.2025 г., 12:56 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Coinbase, Expedia, Affirm, Lyft, Cloudflare, Microchip, Pinterest, and More -- Barrons.com

9.05.2025 г., 12:40 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Coinbase Stock Drops After Earnings. Why Bitcoin $100K, Deribit Acquisition Aren't Boosting Shares. -- Barrons.com

9.05.2025 г., 11:55 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

9.05.2025 г., 11:55 ч. UTC

Пазарно говорене

Bitcoin's High Price Bodes Well for Crypto, Boosts Demand for Ethereum -- Market Talk

9.05.2025 г., 11:26 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Coinbase, Expedia, Affirm, Lyft, Cloudflare, Microchip, Pinterest, and More -- Barrons.com

9.05.2025 г., 10:03 ч. UTC

Топ новини

Investors Dig Into U.K. Trade Deal, Await News of China Talks -- WSJ

9.05.2025 г., 08:17 ч. UTC

Пазарно говорене

Bitcoin Rises to Three-Month High as U.K.-U.S. Trade Deal Sparks Optimism -- Market Talk

8.05.2025 г., 22:16 ч. UTC

Печалби

Coinbase Posts Mixed Earnings Results That Missed Forecasts. The Stock Is Down. -- Barrons.com

8.05.2025 г., 20:24 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Coinbase Posts Mixed Earnings Results That Missed Forecasts. The Stock Is Down. -- Barrons.com

8.05.2025 г., 16:51 ч. UTC

Значими двигатели на пазара
Придобивния, сливания и поглъщания

Coinbase Shares Rise After WSJ Reports Its $2.9B Deal for Major Crypto Platform

8.05.2025 г., 15:34 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Coinbase Stock Climbs Ahead of Earnings. It's Making a Major Acquisition. -- Barrons.com

8.05.2025 г., 13:58 ч. UTC

Пазарно говорене

Bitcoin Eyes $100k, But Traders Brace For Volatility -- Market Talk

8.05.2025 г., 13:01 ч. UTC

Пазарно говорене

Bitcoin Could Hit New All-Time Highs This Quarter -- Market Talk

8.05.2025 г., 13:01 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

8.05.2025 г., 12:45 ч. UTC

Топ новини
Придобивния, сливания и поглъщания

Coinbase Strikes $2.9 Billion Deal for Major Crypto Options Platform -- WSJ

8.05.2025 г., 12:45 ч. UTC

Придобивния, сливания и поглъщания

Coinbase to Buy Crypto Options Platform Deribit in $2.9 Billion Deal, Executives Say -- WSJ

8.05.2025 г., 12:45 ч. UTC

Придобивния, сливания и поглъщания

Coinbase Deal for Deribit to Be Announced Thursday, Executives Say -- WSJ

8.05.2025 г., 12:45 ч. UTC

Придобивния, сливания и поглъщания

Deal Price Consists of $700 Million Cash, 11 Million Coinbase Class A Shares, Executives Say -- WSJ

8.05.2025 г., 08:35 ч. UTC

Пазарно говорене

Bitcoin Hits 3-Month High on Trade Deal Optimism -- Market Talk

7.05.2025 г., 12:07 ч. UTC

Придобивния, сливания и поглъщания

Asset Entities: Reverse Merger Structure Expected to Give the Co Immediate Access to Shelf Registration Statement to Raise Primary Cap

7.05.2025 г., 12:07 ч. UTC

Придобивния, сливания и поглъщания

Asset Entities, Strive Combined Co to Operate Under Strive Brand, Remain Listed on Nasdaq

7.05.2025 г., 12:06 ч. UTC

Придобивния, сливания и поглъщания

Asset Entities Says Combined Co Will Focus Over Time on Maximizing Bitcoin Exposure Per Shar >ASST

7.05.2025 г., 08:09 ч. UTC

Пазарно говорене

Bitcoin Rises on Optimism Over U.S.-China Talks -- Market Talk

6.05.2025 г., 10:19 ч. UTC

Пазарно говорене

Bitcoin Trades Steady as Fed Decision Eyed -- Market Talk

5.05.2025 г., 09:26 ч. UTC

Пазарно говорене

Bitcoin Falls as U.S. Stock Futures Point to Weaker Open; Fed Meeting Eyed -- Market Talk

2.05.2025 г., 07:36 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

2.05.2025 г., 07:36 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

NeoGenomics Inc Прогноза

Ценова цел

By TipRanks

55.28% нагоре

12-месечна прогноза

Среден 12.5 USD  55.28%

Висок 19 USD

Нисък 8.5 USD

Според 14 анализатори от Wall Street, предложили 12-месечна ценова цел за NeoGenomics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

14 ratings

9

Купи

5

Задържане

0

Продай

Техническа оценка

By Trading Central

7.7 / 10.27Подкрепа & съпротива

Краткосрочен план

Very Strong Bearish Evidence

Средносрочен план

Bearish Evidence

Дългосрочен план

Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.